Ryman’s turnaround is well under way: Forsyth Barr

Ryman’s turnaround is well under way: Forsyth Barr
Forsyth Barr's Aaron Ibbotson rates Ryman shares as "outperform". (Image: Forsyth Barr)
Jenny Ruth
Forsyth Barr analyst Aaron Ibbotson has taken a deep dive into Ryman Healthcare‘s debt position and its turnaround strategy and concluded it is “changing its stripes more than the market is giving it credit for”.The market has certainly exhibited extreme disillusion with the stock in recent weeks.Ryman shares fell as low as $4.82 after it completed its $902 million capital raising, compared with the rights issue price of $5 per new share and $6.40 before the mid-February announcement.The shares closed at $5.22 on Tuesday.A goo...

More Markets

NZ sharemarket up 0.5% ahead of long weekend
Markets Market Close

NZ sharemarket up 0.5% ahead of long weekend

Pacific Edge's share price fell 7.32%.

Tom Raynel 24 Apr 2025
Pacific Edge suffers another setback in US
Markets

Pacific Edge suffers another setback in US

Shares in cancer diagnostics company Pacific Edge are down 2.44% to $0.120 after another setback in the US market.The US District Court for the Middle District of Pennsylvania has determined that it does not have jurisdiction to review a Local Coverage Determination (LCD) that co...

Staff reporters 24 Apr 2025
Listed retailers stand to gain from Trump tariffs:  Forsyth Barr
Retail

Listed retailers stand to gain from Trump tariffs: Forsyth Barr

Forsyth Barr lifted its KMD Brands target price by 10.4% after Trump tariff walkbacks.

Gregor Thompson 24 Apr 2025
NZ sharemarket rises as Trump backs down
Markets Market Close

NZ sharemarket rises as Trump backs down

The S&P/NZX 50 Index closed up 1.01% or 119.78 points.

Tom Raynel 23 Apr 2025